The study, which showed that hydrocelin is non-pyrogenic, was part of a series of preclinical tests into several safety ...

Q1 2025 Earnings Call Transcript April 15, 2025 Operator: Good morning, and welcome to FB Financial Corporation’s First ...

Webull's shares soared 370%+ on debut, but with overvaluation risks looming, analysts suggest a 'Strong Sell.' ...

Owning proven dividend growth stocks can help investors during times of market volatility. Read more about three Dividend ...

Preclinical presentation highlights key, modality specific, pharmacological differentiations of VG-3927 - - First presentation of topline ...

business profile and enterprise risk management from event such as hail, wildfires and tornadoes. The presentation will take ...

SEMDEXA™ (SP-102) is a trademark owned by Semnur Pharmaceuticals, Inc., a wholly-owned subsidiary of Scilex Holding Company. A proprietary name review by the FDA is planned. ZTlido ® is a registered ...

Two generously sized compartments and two standard sections let operators customize portions exactly how they want them.

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting ... that we announce or publish may change, or the product ...

As the global sugarcane industry faces growing pressures, leading to factory closures, job losses and reduced cultivation, it is essential to diversify beyond traditional sugar products and increase ...

Lined up for the FDA in the coming weeks are a cell-based gene therapy for a rare skin disease and two product expansions for ...

GT-02287 oral presentation demonstrates new evidence of disease-modifying capacity in GBA1 and idiopathic Parkinson's disease ...